Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections - Wikidata - thesis-toulmin - TriplyDB

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

http://www.wikidata.org/entity/Q28236279

about

Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.In vitro metacestodicidal activities of genistein and other isoflavones against Echinococcus multilocularis and Echinococcus granulosus Repurposing drugs for the treatment and control of helminth infections Novel amidines and analogues as promising agents against intracellular parasites: a systematic review Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori Nitazoxanide inhibits biofilm formation by Staphylococcus epidermidis by blocking accumulation on surfaces.Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.Thiazole, oxadiazole, and carboxamide derivatives of artemisinin are highly selective and potent inhibitors of Toxoplasma gondii.Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review.A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides.EFFICACY OF NITAZOXANIDE AGAINST Toxocara canis: LARVAL RECOVERY AND HUMORAL IMMUNE RESPONSE IN EXPERIMENTALLY INFECTED MICE.Thiazolides promote apoptosis in colorectal tumor cells via MAP kinase-induced Bim and Puma activation.Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds.Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.Evaluation of nitazoxanide and oxfendazole efficacy against cystic echinococcosis in naturally infected sheep.Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.Current treatment options for Dientamoeba fragilis infections.Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options.Echinococcus metacestodes as laboratory models for the screening of drugs against cestodes and trematodes.Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.Nitazoxanide: nematicidal mode of action and drug combination studies.4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.Evaluating 5-Nitrothiazoles as Trypanocidal Agents.The discovery of medicines for rare diseases Anthelmintic discovery and development in the animal health industry.Amixicile, a novel strategy for targeting oral anaerobic pathogens.Norovirus: new developments and implications for travelers' diarrhea.Tizoxanide pyridine monosolvate.Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2).Effect of nitazoxanide on erythrocytes.Time-dependent therapeutic roles of nitazoxanide on high-fat diet/streptozotocin-induced diabetes in rats: Effects on hepatic PPAR-γ receptors.In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.

P2860

Q21144496-21D55E7B-9F18-4082-B529-B4F9E6E8214B Q24616179-40540671-CACF-4B79-B3CA-CB59B5B4B3D1 Q24674880-4C8EAAE0-3756-4095-8277-0F501365DE83 Q26823355-EB2CE337-8A26-4A1A-A55C-0246669BCD25 Q26825025-A778AABE-0E32-4718-818D-32478761AF7E Q26863285-004AD359-CBD7-4A49-A1BE-BBA632088DC3 Q28483646-FB5CD73A-77B1-4540-A111-F3837F2F119A Q28535341-D36F441B-45AE-4C17-9766-7516B80C9AF3 Q30408277-F5723B76-9B89-479B-9C5A-381BA17B38EF Q30433594-66466580-7D1D-46D9-A7D0-62D74D0A02BE Q30434600-F27288BE-C7B3-49DF-9D22-4BF741029917 Q33833620-11864EC8-24F4-41FD-9CC3-81F3C0AF3838 Q34531388-90D13A37-AB7D-4582-8430-4E3A5546B5C5 Q34793715-E7A7AB70-FE09-4DFB-8AA6-285DAF8F5F96 Q35044119-08AA1334-929A-4A11-8527-0C534EA5A680 Q35840867-60030C57-04D3-4B3F-9FEE-6B9733E0D49E Q36196130-78DA2401-F45E-4FEF-A572-9EFEF31549D6 Q36347320-E4B29091-1F92-4C7A-8BAF-06898E9419AD Q36430423-80E883A1-DDBD-40D3-811C-455102A6D15D Q36745310-673000B0-42DB-4EB9-964E-6AE25379A637 Q36882080-11808AE1-D2A3-4207-A478-16BAC77FBF06 Q37169024-41D7A694-B6C5-42F7-BF37-74996A38ACA9 Q37390491-CF70971E-584C-40FA-A18A-6B003ED6F067 Q37390538-36687C8F-E60F-419E-988A-D5AD38E6D1BE Q37417747-3B17E470-21EF-4C98-A5E6-78B494B5B269 Q37599990-AB08A370-5302-4C82-AAB3-F81017E534E2 Q37643702-358E0DC3-55D9-44FC-ADE4-4E137097166A Q37678601-8C10FE6A-649B-49CB-B056-E0A0A31CA745 Q37700104-B24381DB-C4A9-471E-AA37-C124C6CACB18 Q38367643-16F22329-DD24-4392-8C3D-9E8AEDFE8731 Q39152821-DCB5A538-FA3E-4346-B846-FE429DDCCE9D Q39602481-5B689B02-3538-4E85-B0FD-221CCBD9791C Q40065646-2E69F925-E1ED-4E12-B16D-0B1369500118 Q40988466-CA607F2A-E685-4CFB-A705-6AE17FDC7537 Q41910613-55025F44-CC18-4360-9805-2C6A9649D461 Q42114388-9C248E3C-1D27-4940-B934-1D759E01F83E Q45219788-3A4BC265-0024-4BC4-BB75-645CA8D3F6DB Q45882294-97EBAFC3-855F-4478-9422-49DA0C75F52C Q47289745-1BCA46B3-A5C5-4BA4-8AFE-A99F874CDEDB Q50051086-E38F7A08-929C-4890-8AF4-7B0ED72664C3

P2860

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

http://www.wikidata.org/entity/Q28236279

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@ast

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@en

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@nl

type

label

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@ast

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@en

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@nl

prefLabel

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@ast

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@en

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@nl

P1433

Q28236279-735EBFA9-4CF7-4561-8E93-B47948C793EE

P1476

Q28236279-7B499322-F71D-433F-9FD0-A48728FF6E67

P2093

Q28236279-6781B691-9F86-4152-8EBB-999189AF8217

Q28236279-AF002FEF-3F1F-4EA5-90EE-D7CDE69F795A

Q28236279-EC157AA1-1E4F-4BF4-810A-AF3CAEF2969F

P2860

Q28236279-03356218-7A42-49B0-8ECB-F15FC84AABBA

Q28236279-094C393B-F5C1-4B67-9A9B-F1139A53B13B

Q28236279-10C37F0E-4B80-4D55-B7F6-B82E6273E2A4

Q28236279-129AB5F2-8A53-404B-8B99-980E08693359

Q28236279-1780D000-02D9-49AA-99B5-54BF2114F88D

Q28236279-1BFE2514-4796-4838-97A9-341BC8C38377

Q28236279-285FF961-688D-44EC-8806-588DC1C19949

Q28236279-28C6A41F-6DEB-4913-BB7D-3EB10F1C86FF

Q28236279-30413AAA-1E06-40CD-AC1B-D0B2E4CE28D7

Q28236279-34FB5A8D-B86C-4192-9349-9340D53AA96D

P304

Q28236279-24ADA9D4-9C29-43EB-820D-4B2B4947533C

P31

Q28236279-0C664E4F-6D28-443A-A72C-C3369205CE25

Q28236279-f4355426-684e-4d02-86e9-7fe39ccc17ad

P356

Q28236279-A26D8846-83C7-4B56-A279-EF2FFF3C0AD6

P407

Q28236279-24B5AF6A-EE18-4474-BE56-FB560B1DBA88

P433

Q28236279-3B23E135-BFE6-4863-85F7-9696DD5DCE57

P478

Q28236279-9122B3A9-F761-472A-87F3-6169A2733F0C

P577

Q28236279-3DB6AA31-B17C-40B8-A3EF-4C5761B6AB9F

P5875

Q28236279-F4A400B6-266D-4314-A27F-C21BC925AE3C

P698

Q28236279-BB7BE083-7AA1-4AE8-BC89-8A21706C1FD7

P356

14656566.7.7.953

P1433

Expert Opinion on Pharmacotherapy

P1476

Nitazoxanide, a broad-spectrum ...... of gastrointestinal infections

@en

P2093

Andrew Hemphill

http://www.w3.org/2001/XMLSchema#string

Joachim Mueller

http://www.w3.org/2001/XMLSchema#string

Marco Esposito

http://www.w3.org/2001/XMLSchema#string

P2860

Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori.

Nitazoxanide: a new broad spectrum antiparasitic agent

Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture

Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses

The plasma membrane of microaerophilic protists: oxidative and nitrosative stress.

In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group.

Inhibitory activities of epidermal growth factor receptor tyrosine kinase-targeted dihydroxyisoflavone and trihydroxydeoxybenzoin derivatives on Sarcocystis neurona, Neospora caninum, and Cryptosporidium parvum development.

Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru.

Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study.

Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico.

P304

953-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.7.953

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7145577

http://www.w3.org/2001/XMLSchema#string

P698

16634717

http://www.w3.org/2001/XMLSchema#string